First Allied Advisory Services’s Calithera Biosciences, Inc CALA Stock Holding History

First Allied Advisory Services’s Portfolio CALA Stock Details CALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$129K	Buy	1,875 +200	+12%	+$17.5K	﹤0.01%	1121
2020 Q2	$177K	Buy	+1,675	New	+$199K	0.01%	1025
2018 Q1	–	Sell	-558	Closed	-$94K	–	1528
2017 Q4	$94K	Buy	+558	New	+$143K	﹤0.01%	1210

Other funds holding CALA

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Allied Advisory Services's CALA Position: Q3 2020 in Review

First Allied Advisory Services increased its Calithera Biosciences, Inc (CALA) stake by 12% in Q3 2020, buying an estimated $17.5K and bringing the position to 1,875 shares worth $129K. The position accounts for ﹤0.01% of the portfolio, ranked #1121.

First Allied Advisory Services first reported a position in CALA in Q4 2017 and has held it in 3 quarters since. The position peaked at $177K in Q2 2020. 97 funds tracked by Wall St. Rank hold CALA as of Q3 2020.

First Allied Advisory Services held 1,875 shares of Calithera Biosciences, Inc worth $129K as of Q3 2020.
First Allied Advisory Services bought 200 Calithera Biosciences, Inc shares in Q3 2020, an estimated $17.5K.
Calithera Biosciences, Inc made up ﹤0.01% of First Allied Advisory Services's portfolio in Q3 2020, its #1121 holding.
First Allied Advisory Services first reported a position in Calithera Biosciences, Inc in Q4 2017 and has held it in 3 quarters since.
First Allied Advisory Services's Calithera Biosciences, Inc position peaked at $177K in Q2 2020.
97 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q3 2020.

Based on First Allied Advisory Services's 13F filing for Q3 2020, filed 13 Nov 2020.